| Code No. | M101-3 | |
| Anti-CD13 (Mouse) mAb | ||
| Size | 100 µL (1 mg/mL) | |
| Availability (in Japan) | 10 or more
(In Japan at 17:01, Dec 8, 2025 in JST) |
|
| Clonality | Monoclonal | |
| Clone | 123H1 | |
| Isotype (Immunized Animal) |
Rat IgG2b | |
| Applications | IP 5 µg/1000 µL of cell extract from 5x106 cells FCM 5-10 µg/mL (final concentration) |
|
| Immunogen (Antigen) |
C57BL/6 mice-derived dendritic cells | |
| Reactivity [Gene ID] | Mouse[16790] |
|
| Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
| Storage temp. | -20°C | |
| Conjugate | Unlabeled | |
| Manufacturer | MBL | |
| Alternative names | Anpep, Apn, AP-M, AP-N, P150 | |
| Background | CD13 is a myeloid differentiation molecule expressed on committed myeloid progenitors, granulocytes, monocytes, and leukemic cells of myeloid origin. It is also expressed on non-hematopoietic cells including fibroblasts, renal proximal tubule, and small intestine brush-border membrane. The gene for CD13 has recently been cloned the cDNA sequence shows that CD13 is the metalloprotease aminopeptidase N. Biochemical studies have shown that CD13 is a 150 kDa glycoprotein, which exists as a 130 kDa intracellular precursor form. This 130 kDa precursor molecule is posttranslationally modified in the Golgi apparatus to produce the 150 kDa mature cell surface form of the molecule. | |
| Product category | Research area:Cell surface antigens | |
| Data | ![]() |
|
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve